Taiwan requires comprehensive product identification through standardized barcoding systems, with many pharmaceutical products utilizing GS1-128 standards for enhanced traceability. Each pharmaceutical unit must bear clear identification markers that enable precise tracking throughout the distribution network. The system emphasizes lot-level traceability as a foundation, with unit-level serialization increasingly implemented for higher-risk medications. This multi-layered identification approach ensures that every pharmaceutical product can be accurately traced back to its specific production batch and manufacturing origin.

Pharmaceutical entities operating in Taiwan must maintain detailed records at every stage of the supply chain, including production, distribution, and sales data. The regulatory framework mandates that all stakeholders—from manufacturers to distributors to retailers—submit comprehensive documentation to the TFDA. This includes batch information, transaction records, and movement data that creates a complete audit trail. The documentation requirements extend to both domestic and imported pharmaceutical products, ensuring uniform traceability standards across the entire market.

Taiwan's pharmaceutical traceability system operates through centralized data management platforms that enable real-time monitoring and oversight by regulatory authorities. All traceability records must be uploaded and made accessible through these government-managed systems, allowing for immediate access during audits, investigations, or recall situations. The centralized approach facilitates rapid response capabilities and ensures that regulatory authorities maintain complete visibility into pharmaceutical supply chain movements across the country.

The TFDA implements strict compliance monitoring through regular inspections, audits, and verification processes to ensure adherence to traceability requirements. Pharmaceutical companies must demonstrate their ability to provide complete tracking information within specified timeframes and maintain systems that meet regulatory standards. Non-compliance can result in significant penalties, including fines, product recalls, and potential suspension of operating licenses. The enforcement framework includes both routine compliance checks and targeted investigations based on risk assessments or safety concerns.